Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.
Press releases published on April 28, 2025
Telix's Illuccix PSMA-PET Imaging Agent Approved in France
GlobeNewswire
·
April 28, 2025
MELBOURNE, Australia, April 29, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET1 imaging agent, Illuccix® (kit for the preparation of gallium-68 gozetotide …
IntegrateRNA offers improved protein engineering capabilities through their sophisticated ncAA-tRNA modification system
EIN Presswire
·
April 28, 2025
NY, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- The Creative Biogene division IntegrateRNA launched a novel platform that enables post-translational protein modification through the use of non-canonical amino acids and engineered transfer RNA. …
Feroot Launches AlphaPrivacy AI: Automating Global Privacy Compliance for Websites and Web Applications
EIN Presswire
·
April 28, 2025
AlphaPrivacy AI platform ensures compliance with GDPR, CCPA, HIPAA, and more, reducing compliance costs by up to 99.9% TORONTO, ONTARIO, CANADA, April 28, 2025 /EINPresswire.com/ -- Feroot Security, a leader in web application security and compliance, …
Significant Paper Published in JAMA on the Effect of Transcranial Pulsed Current Stimulation
EIN Presswire
·
April 28, 2025
SINGAPORE, April 28, 2025 /EINPresswire.com/ -- Singapore-based AscenZion Neuromodulation Co announced the publication of a significant paper on the ‘Effect of transcranial pulsed current stimulation on social functioning in children with autism’ in JAMA …
Vistatec Recognized with Two TITAN Awards for Excellence in Business and Leadership
EIN Presswire
·
April 28, 2025
DUBLIN, IE-D, IRELAND, April 28, 2025 /EINPresswire.com/ -- Vistatec has been awarded two TITAN Awards for achievements in Marketing and Human Resources at the 2025 TITAN Awards. At the TITAN Business Awards, Vistatec was honored with a Gold award for …
May is Melanoma Awareness Month—The Deadliest Skin Cancer. Says 2025 ThreeBestRated® Awarded Dermatologist Mona Mofid
EIN Presswire
·
April 28, 2025
SAN DIEGO, CA, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- ThreeBestRated® updates its listings annually to ensure accuracy and reliability. In their 2025 update, they have picked Dermatologist Mona Mofid as a top-performing dermatologist in San …
ElevateBio Announces Presentations at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
GlobeNewswire
·
April 28, 2025
– Oral and poster presentations will highlight advancements from ElevateBio’s two business units: Life Edit, its gene editing and R…
Dr. Sud Agarwal and iNGENū CRO Lead Asia-Pacific in Complex Trials for Profound Neurodevelopmental Disorders
EIN Presswire
·
April 28, 2025
Dr. Sud Agarwal and iNGENū CRO Lead Asia-Pacific in Complex Trials for Profound Neurodevelopmental Disorders MELBOURNE, AUSTRALIA, April 28, 2025 /EINPresswire.com/ -- iNGENū CRO, a full-service contract research organization headquartered in Australia, …
IgA Nephropathy Foundation Celebrates 21 Years of Advocacy, Awareness, and Progress
EIN Presswire
·
April 28, 2025
Since May 14, 2004, the Foundation has dedicated itself to supporting patients, advancing research, and advocating for early diagnosis and treatment of IgAN. WALL TOWNSHIP, NJ, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- The IgA Nephropathy …
ARCPOINT REPORTS 2024 YEAR END FINANCIAL RESULTS AND ANNOUNCES MANAGEMENT CHANGE
GlobeNewswire
·
April 28, 2025
Greenville, South Carolina, April 28, 2025 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) is pleased to report that it has filed its 2024 year end, audited Financial Statements and related Management Discussion and Analysis as …
TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 28th Annual Meeting
GlobeNewswire
·
April 28, 2025
WALTHAM, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with …
Cellectis présente une approche non virale d’édition du génome et des innovations avec les base editors à l’ASGCT 2025
GlobeNewswire
·
April 28, 2025
NEW YORK, 28 avr. 2025 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth : ALCLS - NASDAQ : CLLS) (la "Société"), société de biotechnologie de stade clinique, qui utilise sa technologie pionnière d'édition de génome pour développer des thérapies cellulaires …
Tevogen Reaffirms Oncology Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion
GlobeNewswire
·
April 28, 2025
Reflects business philosophy of commercial success through patient accessibility Recently executed agreement with CD 8 Technology Services LLC providing up to $50 million for Company’s dedicated R&D and manufacturing facility; no impact on shareholder …
Artiva Biotherapeutics to Present Longer-term Phase 1/2 Data for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting
GlobeNewswire
·
April 28, 2025
Prolonged duration of response, deep B-cell depletion, and well-tolerated safety profile support the potential of AlloNK® + rituximab for the treatment of B-cell driven diseases in a community setting Additional poster presentation to feature scalability …
Arbor Biotechnologies to Present Foundational Data for PH1 and CNS Programs at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
GlobeNewswire
·
April 28, 2025
- Oral presentation to include preclinical data supporting the clinical advancement of ABO-101 for the treatment of primary hyperoxaluria type 1 - Four poster presentations collectively demonstrate advancement of company’s differentiated CNS gene editing …
Editas Medicine to Present Preclinical Data Demonstrating Progress in the Development of an in vivo Gene Editing Pipeline at the American Society of Gene and Cell Therapy Annual Meeting
GlobeNewswire
·
April 28, 2025
CAMBRIDGE, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company, today announced that five abstracts have been accepted for presentation, including one oral presentation, at the 28th Annual …
Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference
GlobeNewswire
·
April 28, 2025
TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, announced today that the company will participate …
Spur Therapeutics Announces Oral and Poster Presentations Highlighting Data from Clinical and Preclinical Programs at Upcoming ASGCT Annual Meeting
GlobeNewswire
·
April 28, 2025
LONDON, April 28, 2025 (GLOBE NEWSWIRE) -- Spur Therapeutics today announced that it will share new data from its gene therapy programs in Gaucher disease, GBA1 Parkinson’s disease and adrenomyeloneuropathy in oral and poster presentations at the American …
Axovia Therapeutics Announces Three Upcoming Poster Presentations at ASGCT
GlobeNewswire
·
April 28, 2025
LONDON, April 28, 2025 (GLOBE NEWSWIRE) -- Axovia Therapeutics Ltd., a biotechnology company developing therapies to address the genetic causes of blindness and obesity, today announced that Co-Founder and Chief Scientific Officer, Dr. Victor Hernandez, …
Shape Therapeutics Announces Multiple Oral and Poster Presentations at the American Society of Gene & Cell Therapy 28th Annual Meeting
GlobeNewswire
·
April 28, 2025
SEATTLE, April 28, 2025 (GLOBE NEWSWIRE) -- Shape Therapeutics, a leader in RNA-based gene therapy, today announced the acceptance of multiple abstracts, including two oral presentations, at the upcoming 28th Annual Meeting of the American Society of Gene …